Process Development

• A true transient expression system that can handle the complex and novel candidates emerging from today’s pipelines
• Proprietary approaches to drive higher overall product yields including enhancement of gene expression and increased downstream unit operation productivity
• Development of target product profiles with customized N-glycosylation

To ensure seamless scale-up to commercial production levels, iBio’s pilot facility uses the same biomass production and downstream processes as the cGMP facility. In fact, the pilot facility was designed as a direct scale-down from the manufacturing facility and is fully integrated within the manufacturing site to improve technology transfer efficiency.

• Milligram to gram quantities
• Process optimization — from expression to formulation
• Technology transfer ready — processes designed for scale
• Protein characterization to meet your needs